HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid.

Abstract
Bullous pemphigoid is an autoimmune subepidermal blistering disease associated with autoantibodies against BP180 and BP230. We report herein a rare case of bullous pemphigoid with newly formed annular erythematous lesions when bullous skin lesions were in remission. Various immunological studies revealed immunoglobulin (Ig)A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in addition to IgG antibodies against BP180 and BP230. These clinical and immunological changes in a patient are a rare event, suggesting an epitope-spreading phenomenon.
AuthorsFumi Yamaki, Nobuyasu Mayuzumi, Shigaku Ikeda, Takashi Hashimoto
JournalThe Journal of dermatology (J Dermatol) Vol. 37 Issue 3 Pg. 255-8 (Mar 2010) ISSN: 1346-8138 [Electronic] England
PMID20507390 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • Desmoglein 1
  • Immunoglobulin A
  • Membrane Proteins
  • PPL protein, human
  • Plakins
  • Protein Precursors
  • envoplakin
  • Dapsone
  • Prednisolone
Topics
  • Aged, 80 and over
  • Autoantibodies (blood, immunology)
  • Basement Membrane (immunology)
  • Dapsone (therapeutic use)
  • Desmoglein 1 (immunology)
  • Female
  • Humans
  • Immunoglobulin A (blood, immunology)
  • Membrane Proteins (immunology)
  • Pemphigoid, Bullous (drug therapy, immunology)
  • Plakins (immunology)
  • Prednisolone (therapeutic use)
  • Protein Precursors (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: